Maggie L DiNome

19PUBLICATIONS
34CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersOncology and carcinogenesis not elsewhere classifiedMolecular targetsEngineering electromagnetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Sep 21, 2026
Patient-Level Evaluation of Optimal Margin Width for Lumpectomy in Ductal Carcinoma In Situ: An Analysis of Patients in the National Cancer Database Special Study.

|Sep 15, 2026
Primary Tumor Epigenetic and Transcriptomic Alterations Associated with Nodal Burden and Metastatic Risk in ER+/HER2- Breast Cancer.

|Mar 26, 2025
Risk Stratification for Sentinel Lymph Node Positivity in Older Women With Early-Stage Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2 Neu-Negative Invasive Breast Cancer.

Ton Wang, Drew Neish, Samantha M Thomas

|Feb 23, 2024
Racial/Ethnic Disparities in Pathologic Complete Response and Overall Survival in Patients With Triple-Negative Breast Cancer Treated With Neoadjuvant Chemotherapy.

Hannah E Woriax, Samantha M Thomas, Jennifer K Plichta

|Aug 25, 2023
A Pilot Study of Neoadjuvant Nivolumab, Ipilimumab, and Intralesional Oncolytic Virotherapy for HER2-negative Breast Cancer.

Vina P Nguyen, Katie M Campbell, Theodore S Nowicki

|Jul 10, 2023
Construction and validation of a gene expression classifier to predict immunotherapy response in primary triple-negative breast cancer.

Miquel Ensenyat-Mendez, Javier I J Orozco, Pere Llinàs-Arias

Pageof 4

Frequent Collaborators

3 joint publications

Jennifer K Plichta

3 joint publications

Laura H Rosenberger

2 joint publications

Astrid Botty van den Bruele

2 joint publications

Samantha M Thomas